On Oct.25, 2011, Tianjin Ringpu Bio-technology Co., Ltd. (300119.SZ) published its Q1-Q3 Report disclosing that in Jan.-Sep., 2011, it gained operating revenue of RMB 430 million, up 78.3% YoY, and net income of RMB 85 million, up 37.0% YoY. The rapid growth of its performance was mainly driven b...
From Jan. to Sep. in 2011, Chongqing Zhifei Biological Products Co., Ltd attainted operating revenue of RMB 460 million and net income of RMB 130 million, down 3.3% and 25.5% separately from the sa...
On Oct. 11, 2011, Anhui Anke Biotechnology (Group) Co., Ltd. (300009.SZ) announced that its PEG Long-Acting Human Growth Hormone Injection has won the clinical trial approvalfrom State Food and Dru...
On October 13th, 2011, Hualan Biological Engineering Inc. (002007.SZ) annouced that the second flu vaccine workshop and the No. 4, No.5, No.6 packaging lines in packaging section 2 of its subsidiar...
On June 27 and 29, 2011, KHB (002022.SZ) was in succession granted with ‘Medical Device Registration Certificate’ issued by Shanghai Municipal Food and Drug Administration and the State...
In 2011H1, operating revenue of Walvax Biotechnology reached RMB180 million, up 42.6% YoY; while its net income achieved RMB84 million, up 48.2% YoY. Meanwhile, HiB vaccine generated revenue of RMB...
From January to June in 2011, the operating revenue of Jinyu Group registered RMB 240 million, down 18.0% YoY, with net income reaching RMB 63.83 million, up 12.1% YoY. The growth of net income cou...
North China Pharmaceutical announced on Sep 15, 2011 that its gene recombinant human albumin had obtained Drug Manufacturing Certificate from Hebei Food and Drug Administration, symbolizing the acq...
Operating revenue of Hepalink Pharmaceutical reached RMB1.57 billion in 2011H1, a decline of 13% YoY; meanwhile, its operating profit achieved RMB420 million, down 40.3% YoY. The main reason for th...
Beijing SL Pharmaceutical announced on 13th Aug, that it will invest RMB130 million to set up joint-venture PnuVax SL with Canadian company PnuVax Incorporated. SL Pharmaceutical and PnuVax will ho...
On 16 Aug. 2011, Hualan Biological released its semi-annual report, according to which, its operating revenue reached RMB470 million, a decline of 23.6% YoY; meanwhile, its net profit achieved RMB2...
Influenced by the price rise of natural rubber, profitability of Gui Zhou Tyre declined in 2011H1
On 18 Aug. 2011, Gui Zhou Tyre(000589.SZ) released its semi-annual report, according to which, ...